Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials | Contract Pharma

What are you searching for?

Sign in

Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Selkirk Pharma, a U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, has launched ClinFAST, a service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies. By reducing production timelines while maintaining high-quality standards, ClinFAST addresses a challenge faced by drug developers—securing fill/finish capacity in a market where small-batch projects are often deprioritized by larger contract manufacturing organizations (CMOs).

“In clinical drug development, time is everything. Delays in sterile fill/finish can mean missed trial milestones and significant financial setbacks,” said Colleen Dixon, CEO of Selkirk Pharma. “ClinFAST represents a significant advancement in our ability to ensure biotech and pharma companies can access the high-quality drug product manufacturing they need—without the typical wait times. Our experienced team, best-in-class equipment, and commitment to excellence mean our clients can trust us to help them stay on track and bring life-saving treatments to patients faster.”

A faster path to clinical trials without sacrificing quality

The traditional fill/finish landscape presents major hurdles for small-volume projects, with waiting periods ranging from 6 to 12 months for an available slot. ClinFAST eliminates these delays by running production processes in parallel and leveraging a templated approach that streamlines each step—from compounding to final release. Selkirk Pharma maintains an on-site inventory of ISO-sized vials, stoppers, filling assemblies, and excipients, reducing the lead time required for sourcing materials. The company also offers flexibility for clients to incorporate customer-supplied materials that align with the ClinFAST process.

Key advantages of ClinFAST:

• Rapid turnaround: Delivers clinical trial materials in a fraction of the time required by larger CMOs.

• Batch sizes up to 10,000 vials: Ideal for liquid-filled vials used in Phase 1 and 2 trials.

• High-yield processing: State-of-the-art equipment minimizes line-loss and ensures consistent filled-container yields.

• Scalability: Capable of supporting clients beyond clinical trials with commercial-scale manufacturing capacity.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters